<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17327" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Albright Hereditary Osteodystrophy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sarathi</surname>
            <given-names>Vijaya</given-names>
          </name>
          <aff>Vydehi Institute of Medical Sciences and Research Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wadhwa</surname>
            <given-names>Roopma</given-names>
          </name>
          <aff>South Carolina Department of Mental Health</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vijaya Sarathi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Roopma Wadhwa declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17327.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Albright hereditary osteodystrophy (AHO) is a hereditary condition due to inactivating GNAS1 gene mutation. AHO is characterized by a round face, short stature with a stocky habitus, brachydactyly, subcutaneous ossification, and dental anomalies. AHO may be associated with hormonal resistance in patients with pseudohypoparathyroidism type 1A and 1C and is often the first clue for their diagnosis. In addition, one or more features of the AHO phenotype may be present in other disorders which should be distinguished from AHO. This activity highlights the role of the interprofessional team in the diagnosis and management of patients with Albright hereditary osteodystrophy.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the etiopathogenesis of Albright hereditary osteodystrophy.</p></list-item><list-item><p>Summarize the evaluation of Albright hereditary osteodystrophy.</p></list-item><list-item><p>Outline the management options available for Albright hereditary osteodystrophy.</p></list-item><list-item><p>Explain interprofessional team strategies for improving care coordination and communication to improve the outcomes of patients with Albright hereditary osteodystrophy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17327&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17327">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17327.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Albright hereditary osteodystrophy (AHO) phenotype was first described in 1942 by Fuller Albright.<xref ref-type="bibr" rid="article-17327.r1">[1]</xref>&#x000a0;AHO refers to a constellation of signs, including a round face, short stature with a stocky habitus, brachydactyly, subcutaneous ossification, and dental anomalies.<xref ref-type="bibr" rid="article-17327.r2">[2]</xref> Developmental delay, obesity (early-onset), and relative macrocephaly may be the additional features of AHO.<xref ref-type="bibr" rid="article-17327.r3">[3]</xref><xref ref-type="bibr" rid="article-17327.r4">[4]</xref><xref ref-type="bibr" rid="article-17327.r5">[5]</xref><xref ref-type="bibr" rid="article-17327.r6">[6]</xref><xref ref-type="bibr" rid="article-17327.r7">[7]</xref></p>
      </sec>
      <sec id="article-17327.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>AHO phenotype is commonly observed in pseudohypoparathyroidism (PHP) type 1A, 1C, and pseudo-pseudohypoparathyroidism (PPHP), rarely observed in patients with PHP1B and not described in PHP2.<xref ref-type="bibr" rid="article-17327.r8">[8]</xref><xref ref-type="bibr" rid="article-17327.r9">[9]</xref> PHP occurs due to heterozygous inactivating mutation in the <italic toggle="yes">GNAS1 </italic>gene that codes for &#x003b1;-subunit of the stimulatory G protein. <italic toggle="yes">GNAS </italic>gene is located on the telomeric end of the long arm of chromosome 20 (20q13.2-20q13.3).<xref ref-type="bibr" rid="article-17327.r10">[10]</xref> PHP1A and PHP1C result due to maternally inherited inactivating <italic toggle="yes">GNAS1</italic> mutations, which manifest with AHO phenotype plus hormonal resistance. In contrast, those with paternally inherited <italic toggle="yes">GNAS1</italic> mutations present with the AHO phenotype alone with no hormonal resistance (PPHP). PHP2B results due to methylation abnormalities of <italic toggle="yes">GNAS</italic>.<xref ref-type="bibr" rid="article-17327.r9">[9]</xref></p>
      </sec>
      <sec id="article-17327.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The data regarding the prevalence of Albright hereditary osteodystrophy is limited. The closely related disorder, PHP, has a prevalence of 0.34 to 1.1 per 100,000.<xref ref-type="bibr" rid="article-17327.r11">[11]</xref><xref ref-type="bibr" rid="article-17327.r12">[12]</xref>&#x000a0;However, the prevalence&#x000a0;of PHP is estimated to be approximately 1 per 20,000.<xref ref-type="bibr" rid="article-17327.r13">[13]</xref></p>
      </sec>
      <sec id="article-17327.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>In addition to PTH resistance, PHP1A and PHP1C are also associated with resistance to other hormones such as thyroid-stimulating hormone (TSH), growth hormone-releasing hormone (GHRH), gonadotropins, and calcitonin.<xref ref-type="bibr" rid="article-17327.r14">[14]</xref> Skeletal abnormalities in Albright hereditary osteodystrophy include shortening of all long bones, but bones of hands and feet are the most affected. Short bones are not present at birth and manifest as the child grows due to premature closure of epiphyses, which reduces the period of growth.<xref ref-type="bibr" rid="article-17327.r15">[15]</xref> Ectopic ossification, another characteristic feature of AHO, refers to extraskeletal bone formation (intramembranous ossification) and is not synonymous with ectopic calcification. Formation of ectopic ossification is not related to serum calcium and phosphorus levels but is the result of Gs-alpha deficiency in the mesenchymal stem cells, which leads to their differentiation into osteoblasts at extraskeletal sites such as subcutaneous tissue and dermis and the consequent new bone formation.<xref ref-type="bibr" rid="article-17327.r16">[16]</xref> In PHP1A as well as PPHP, the extent of subcutaneous ossifications positively correlates with the severity of the mutations (more severe in patients with frames-shift and nonsense mutations).<xref ref-type="bibr" rid="article-17327.r17">[17]</xref></p>
        <p>Short stature, a common feature of AHO, results due to various reasons. Few patients may have intrauterine growth retardation, but the growth deficit becomes more apparent over time due to reduced growth velocity after few years of birth, compromised pubertal growth spurt, and premature cessation of growth due to early fusion of epiphyses.<xref ref-type="bibr" rid="article-17327.r13">[13]</xref>&#x000a0;The latter probably results due to&#x000a0;insufficient signaling at the PTH/PTHrP receptor, which results in accelerated differentiation of proliferating chondrocytes into hypertrophic cells.&#x000a0;GHRH resistance and consequent growth hormone deficiency also partly contributes to growth failure.<xref ref-type="bibr" rid="article-17327.r13">[13]</xref> Reduced energy expenditure, rather than excess energy consumption, has been demonstrated as the cause of early-onset obesity in a few recent studies.<xref ref-type="bibr" rid="article-17327.r18">[18]</xref><xref ref-type="bibr" rid="article-17327.r19">[19]</xref></p>
      </sec>
      <sec id="article-17327.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Adult short stature is a common finding and seen in 80% of PHP1A and 50% to 70% of PPHP patients.<xref ref-type="bibr" rid="article-17327.r15">[15]</xref> Short stature is usually present during childhood, and a height percentile lower than that of an unaffected sibling or parent is usually observed. Small for gestational age (SGA) may be observed in few. Obesity is less commonly found, but most often has early-onset (before 2 years of age) with a round face.<xref ref-type="bibr" rid="article-17327.r20">[20]</xref> Subcutaneous hard nodules representing ectopic ossification, often in the form of plaque shape, may be present. Heterotopic (subcutaneous) ossifications are equally common among PHP1A and PPHP.<xref ref-type="bibr" rid="article-17327.r17">[17]</xref></p>
        <p>Short fourth and/or fifth metacarpals present as dimpling over the respective knuckles, which is also called &#x02018;Archibald sign.&#x02019; When the fourth metacarpal is short, it forms the knuckle, knuckle, dimple, knuckle sign, whereas shortening of both fourth and fifth metacarpals leads to the knuckle, knuckle, dimple, dimple sign. The shortening of the distal phalanx of the thumb (murderer&#x02019;s thumb or potter&#x02019;s thumb) is the most common abnormality among AHO.<xref ref-type="bibr" rid="article-17327.r21">[21]</xref> Brachydactyly may not be apparent at birth and may develop during childhood or adolescence.<xref ref-type="bibr" rid="article-17327.r15">[15]</xref> Dental abnormalities are seen in a few patients and include failure of eruption of teeth, short blunted roots, altered dental pulps, hypodontia, and enamel hypoplasia.<xref ref-type="bibr" rid="article-17327.r22">[22]</xref> Mild developmental delay and cognitive impairment may be present.</p>
        <p>Clinical features of hypocalcemia may be present. Symptoms of hypocalcemia include jitteriness, seizures, and laryngeal stridor in infants and carpopedal spasm in children or adults. Symptoms of milder hypocalcemia include perioral numbness, paraesthesia, muscle cramps, carpopedal spasm (the sign of overt hypocalcemia), Chvostek and Trousseaus signsn.</p>
      </sec>
      <sec id="article-17327.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Initial biochemical evaluation should include evaluation for PTH resistance (serum calcium, serum albumin, and serum phosphorus). Hypocalcemia, hyperphosphatemia, and elevated PTH in the absence of hypovitaminosis D, hypomagnesemia, and renal dysfunction are diagnostic of PTH resistance. In the setting of AHO, PTH resistance should be suspected even when serum calcium is normal if PTH is at high-normal to high with normal 25-hydroxy vitamin D.<xref ref-type="bibr" rid="article-17327.r15">[15]</xref> If evidence of PTH resistance is present, evaluation for other hormonal resistance (serum thyroid-stimulating hormone and serum-free thyroxine) should be conducted. Usually, thyroid-stimulating hormone (TSH) is mildly elevated. All patients with PTH resistance, especially those with short stature, should be subjected to GH-IGF1 axis evaluation. Evaluation of gonadotropin resistance should be considered only in patients with pubertal delay.</p>
        <p>Skeletal maturation should be monitored with roentgenography of the left hand at regular intervals. Roentgenography may also reveal short metacarpals, metatarsals, distal phalanges of thumbs, advanced bone age, and ectopic ossification.</p>
        <p>Electrocardiogram may reveal prolonged QT in patients with hypocalcemia.</p>
        <p>Computed tomography of the brain may reveal basal ganglia calcification and, in more severe cases, more diffuse calcification involving the subcortical white matter (Fahr syndrome).</p>
      </sec>
      <sec id="article-17327.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Patients with pseudohypoparathyroidism are treated with oral calcium supplementation, calcitriol, and dietary phosphate restriction. Subclinical hypothyroidism may be treated with levothyroxine replacement. Growth hormone treatment is recommended for patients with a documented growth hormone deficiency, usually at doses used for SGA.<xref ref-type="bibr" rid="article-17327.r15">[15]</xref>&#x000a0;Sex steroid replacement should be offered in patients with delayed puberty due to gonadotropin resistance.</p>
      </sec>
      <sec id="article-17327.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Individual features of Albright hereditary osteodystrophy are not unique to pseudohypoparathyroidism and are observed in other disorders as described below.<xref ref-type="bibr" rid="article-17327.r23">[23]</xref>&#x000a0;AHO should be distinguished from the below-described disorders, which closely mimic AHO.</p>
        <p><bold>Brachydactyly-mental retardation syndrome or AHO-like syndrome (<italic toggle="yes">HDAC4 </italic>loss of function mutation or 2q37 microdeletion):</bold> Brachydactyly, obesity, developmental delay, mental retardation, behavioral disorders are the common manifestations. Mild PTH resistance may be observed in AHO-like syndrome but not ectopic ossification.<xref ref-type="bibr" rid="article-17327.r24">[24]</xref></p>
        <p><bold>iPPSD4 or Acro-dysostosis type 1 (<italic toggle="yes">PRKRA1A</italic> mutation):</bold> Facial dysostosis and nasal hypoplasia, generalized, severe brachydactyly, and PTH resistance &#x000b1; other hormonal resistance. A subset of patients with AHO with no abnormalities in the&#x000a0;<italic toggle="yes">GNAS1</italic> gene have mutations in the&#x000a0;<italic toggle="yes">PRKRA1A</italic> gene.<xref ref-type="bibr" rid="article-17327.r25">[25]</xref></p>
        <p><bold>iPPSD5 or Acro-dysostosis type 2 (<italic toggle="yes">PDE4D</italic> mutation):</bold> Generalised and severe brachydactyly type E, facial dysostosis and nasal hypoplasia, mental retardation, decreased interpeduncular distance (<italic toggle="yes">PDE4D</italic> loss of function mutation). A subset of patients with AHO with no abnormalities in the GNAS1 gene have mutations in the PDE4D gene.<xref ref-type="bibr" rid="article-17327.r25">[25]</xref></p>
        <p><bold>iPPSD6</bold>
<bold>(<italic toggle="yes">PDE3A</italic> mutation):</bold> Short stature, brachydactyly E, hypertension, posterior inferior cerebellar artery loop.</p>
        <p><bold>Isolated brachydactyly E</bold>: <italic toggle="yes">HOXD13</italic> mutation.</p>
        <p><bold>Brachydactyly E with short stature, PTHLH type</bold>
<bold>(<italic toggle="yes">PTHLH</italic> mutation):</bold> Dental problems, learning difficulties, facial dysmorphism</p>
        <p><bold>Trichorhinophalangeal syndrome</bold>: Milder generalized brachydactyly E without carving of the phalangeal epiphyses, sparse hair, bulbous tip of the nose, thin upper lip, growth hormone deficiency, hip malformation.</p>
        <p><bold>Turner syndrome</bold>: Short stature, short IV metacarpal (no shortening of TP1), ovarian insufficiency, cubitus valgus, Madelung deformity</p>
      </sec>
      <sec id="article-17327.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>There is limited information regarding the prognosis of Albright hereditary osteodystrophy. Life expectancy is usually normal in patients with AHO. Severe-morbid obesity with associated complications such as obstructive sleep apnea, neuropsychiatric disorders, seizures, and cataracts are more common in AHO associated with PHP1A.<xref ref-type="bibr" rid="article-17327.r12">[12]</xref></p>
      </sec>
      <sec id="article-17327.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Associated PTH resistance resulting in chronic hypocalcemia and hyperphosphatemia can lead to basal ganglia and subcortical white matter calcification and consequent neuropsychiatric disorders, movement disorders, and parkinsonism.<xref ref-type="bibr" rid="article-17327.r12">[12]</xref><xref ref-type="bibr" rid="article-17327.r26">[26]</xref><xref ref-type="bibr" rid="article-17327.r27">[27]</xref></p>
        <p>The prevalence of carpal tunnel syndrome is higher in patients with AHO.<xref ref-type="bibr" rid="article-17327.r28">[28]</xref></p>
        <p>Increased risk for sleep apnea has been reported in children with PHP1A.<xref ref-type="bibr" rid="article-17327.r29">[29]</xref></p>
        <p>Insulin sensitivity is reduced in patients with PHP1A, which increases the risk of impaired glucose tolerance in them.<xref ref-type="bibr" rid="article-17327.r30">[30]</xref></p>
        <p>Spinal stenosis is often described in patients with AHO, which can lead to lower extremity paraparesis.<xref ref-type="bibr" rid="article-17327.r31">[31]</xref></p>
        <p>Heterotopic ossifications in or around the joints may rarely result in limited joint movements.<xref ref-type="bibr" rid="article-17327.r32">[32]</xref></p>
      </sec>
      <sec id="article-17327.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Albright hereditary osteodystrophy is an inherited disorder. Once the disease is developed, there is no cure. However, regular screening for the associated manifestations, irrespective of the symptoms, helps to identify them early and helps in initiating timely treatment. In addition, testing for <italic toggle="yes">GNAS1 </italic>mutations and counseling are useful for patients planning to have children to know the risk of passing on their disease. Children born to affected males usually develop skeletal abnormalities only, whereas those born to affected females also develop hormonal abnormalities.</p>
      </sec>
      <sec id="article-17327.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Albright hereditary osteodystrophy is a rare hereditary disorder. Patients with&#x000a0;AHO may exhibit various signs and symptoms such as a round face, short stature, brachydactyly, subcutaneous ossification, seizures, carpopedal spasms, developmental delay, obesity, dental anomalies, neuropsychiatric disturbances, and parkinsonism.</p>
        <p>Children and adolescents with AHO should schedule an evaluation and follow-up by a pediatric endocrinologist. Presentation with seizure or carpopedal spasm requires care in liaison with health care providers from emergency services. Management of intervening unrelated illnesses needs care from the general pediatrician. Clinical psychologist and/or developmental pediatrician may be involved in assessing the development and intelligence quotient and offering the essential treatment options for the identified abnormalities. A dentist may be consulted to detect and treat the associated dental anomalies. Consultation with a nutritionist is essential to prevent/treat obesity and also to guide a low phosphorus diet in patients with PHP1A and PHP1C. A pharmacist will ensure that the patient is on the right dose of medications prescribed and there are no inadvertent interactions between medications. Consultation with a neuropsychiatrist may be essential for the management of neuropsychiatric disorders, whereas consultation with a neurologist may be needed if movement disorders or parkinsonian features develop. Rarely, consultation with a surgeon and orthopedist may be required in patients with symptomatic heterotopic ossification. [Level 5]</p>
      </sec>
      <sec id="article-17327.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17327&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17327">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/albright-hereditary-osteodystrophy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17327">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17327/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17327">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17327.s15">
        <title>References</title>
        <ref id="article-17327.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MACGREGOR</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>WHITEHEAD</surname>
                <given-names>TP</given-names>
              </name>
            </person-group>
            <article-title>Pseudo-hypoparathyroidism; a description of three cases and a critical appraisal of earlier accounts of the disease.</article-title>
            <source>Arch Dis Child</source>
            <year>1954</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>147</issue>
            <fpage>398</fpage>
            <page-range>398-418</page-range>
            <pub-id pub-id-type="pmid">13208312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mantovani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Elli</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Inactivating PTH/PTHrP Signaling Disorders.</article-title>
            <source>Front Horm Res</source>
            <year>2019</year>
            <volume>51</volume>
            <fpage>147</fpage>
            <page-range>147-159</page-range>
            <pub-id pub-id-type="pmid">30641531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mouallem</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shaharabany</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weintrob</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shalitin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nagelberg</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shapira</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zadik</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Farfel</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>68</volume>
            <issue>2</issue>
            <fpage>233</fpage>
            <page-range>233-9</page-range>
            <pub-id pub-id-type="pmid">17803690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Trembath</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Albright's hereditary osteodystrophy.</article-title>
            <source>J Med Genet</source>
            <year>1994</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>10</issue>
            <fpage>779</fpage>
            <page-range>779-84</page-range>
            <pub-id pub-id-type="pmid">7837255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Albright's hereditary osteodystrophy and pseudohypoparathyroidism.</article-title>
            <source>Semin Musculoskelet Radiol</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>273</fpage>
            <page-range>273-83</page-range>
            <pub-id pub-id-type="pmid">12541184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patten</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Johns</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Valle</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Eil</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gruppuso</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Smallwood</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy.</article-title>
            <source>N Engl J Med</source>
            <year>1990</year>
            <month>May</month>
            <day>17</day>
            <volume>322</volume>
            <issue>20</issue>
            <fpage>1412</fpage>
            <page-range>1412-9</page-range>
            <pub-id pub-id-type="pmid">2109828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Long</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>McGuire</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Weinstein</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Germain-Lee</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>92</volume>
            <issue>3</issue>
            <fpage>1073</fpage>
            <page-range>1073-9</page-range>
            <pub-id pub-id-type="pmid">17164301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zeniya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yuno</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Usui</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Moriki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Uno</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Miake</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>A 22-year-old woman with hypocalcemia and clinical features of albright hereditary osteodystrophy diagnosed with sporadic pseudohypoparathyroidism type Ib using a methylation-specific multiplex ligation-dependent probe amplification assay.</article-title>
            <source>Intern Med</source>
            <year>2014</year>
            <volume>53</volume>
            <issue>9</issue>
            <fpage>979</fpage>
            <page-range>979-86</page-range>
            <pub-id pub-id-type="pmid">24785890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thiele</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mantovani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Barlier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boldrin</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bordogna</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Sanctis</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Elli</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Freson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Garin</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Grybek</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hanna</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Izzi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hiort</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Lecumberri</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pereda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saraff</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Silve</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Turan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Usardi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Werner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>de Nanclares</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Linglart</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>175</volume>
            <issue>6</issue>
            <fpage>P1</fpage>
            <page-range>P1-P17</page-range>
            <pub-id pub-id-type="pmid">27401862</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gejman</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Weinstein</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spiegel</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Hsieh</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Hoehe</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Gershon</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Genetic mapping of the Gs-alpha subunit gene (GNAS1) to the distal long arm of chromosome 20 using a polymorphism detected by denaturing gradient gel electrophoresis.</article-title>
            <source>Genomics</source>
            <year>1991</year>
            <month>Apr</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>782</fpage>
            <page-range>782-3</page-range>
            <pub-id pub-id-type="pmid">1674732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakamura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tamakoshi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kawamura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Seino</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kasuga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yanagawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ohno</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan.</article-title>
            <source>J Epidemiol</source>
            <year>2000</year>
            <month>Jan</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-33</page-range>
            <pub-id pub-id-type="pmid">10695258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Underbjerg</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sikjaer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mosekilde</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rejnmark</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Pseudohypoparathyroidism - epidemiology, mortality and risk of complications.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>84</volume>
            <issue>6</issue>
            <fpage>904</fpage>
            <page-range>904-11</page-range>
            <pub-id pub-id-type="pmid">26387561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Germain-Lee</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Management of pseudohypoparathyroidism.</article-title>
            <source>Curr Opin Pediatr</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>537</fpage>
            <page-range>537-549</page-range>
            <pub-id pub-id-type="pmid">31145125</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levine</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>An update on the clinical and molecular characteristics of pseudohypoparathyroidism.</article-title>
            <source>Curr Opin Endocrinol Diabetes Obes</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>443</fpage>
            <page-range>443-51</page-range>
            <pub-id pub-id-type="pmid">23076042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mantovani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bastepe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Monk</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>de Sanctis</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thiele</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Usardi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Bufo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Choplin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>De Filippo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Devernois</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Eggermann</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Elli</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Freson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a Ramirez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Germain-Lee</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Groussin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hamdy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hanna</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hiort</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>J&#x000fc;ppner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kamenick&#x000fd;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kottler</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Le Norcy</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lecumberri</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>M&#x000e4;kitie</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Martos-Moreno</surname>
                <given-names>G&#x000c1;</given-names>
              </name>
              <name>
                <surname>Minagawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pereda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pignolo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rejnmark</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rodado</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rothenbuhler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saraff</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Shoemaker</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Shore</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Silve</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Turan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Woods</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zillikens</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Perez de Nanclares</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Linglart</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.</article-title>
            <source>Nat Rev Endocrinol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>14</volume>
            <issue>8</issue>
            <fpage>476</fpage>
            <page-range>476-500</page-range>
            <pub-id pub-id-type="pmid">29959430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pignolo</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Billings</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Shore</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification.</article-title>
            <source>J Bone Miner Res</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>26</volume>
            <issue>11</issue>
            <fpage>2647</fpage>
            <page-range>2647-55</page-range>
            <pub-id pub-id-type="pmid">21812029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salemi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Skalamera Olson</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Dickson</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Germain-Lee</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Ossifications in Albright Hereditary Osteodystrophy: Role of Genotype, Inheritance, Sex, Age, Hormonal Status, and BMI.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2018</year>
            <month>Jan</month>
            <day>01</day>
            <volume>103</volume>
            <issue>1</issue>
            <fpage>158</fpage>
            <page-range>158-168</page-range>
            <pub-id pub-id-type="pmid">29059381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perez</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Curley</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Slaughter</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Shoemaker</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Glucose Homeostasis and Energy Balance in Children With Pseudohypoparathyroidism.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2018</year>
            <month>Nov</month>
            <day>01</day>
            <volume>103</volume>
            <issue>11</issue>
            <fpage>4265</fpage>
            <page-range>4265-4274</page-range>
            <pub-id pub-id-type="pmid">30085125</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shoemaker</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Lomenick</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Saville</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Buchowski</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Cone</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Energy expenditure in obese children with pseudohypoparathyroidism type 1a.</article-title>
            <source>Int J Obes (Lond)</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>8</issue>
            <fpage>1147</fpage>
            <page-range>1147-53</page-range>
            <pub-id pub-id-type="pmid">23229731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mantovani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Spada</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Elli</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Pseudohypoparathyroidism and Gs&#x003b1;-cAMP-linked disorders: current view and open issues.</article-title>
            <source>Nat Rev Endocrinol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>12</volume>
            <issue>6</issue>
            <fpage>347</fpage>
            <page-range>347-56</page-range>
            <pub-id pub-id-type="pmid">27109785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poznanski</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Werder</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Giedion</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The pattern of shortening of the bones of the hand in PHP and PPHP--A comparison with brachydactyly E, Turner Syndrome, and acrodysostosis.</article-title>
            <source>Radiology</source>
            <year>1977</year>
            <month>Jun</month>
            <volume>123</volume>
            <issue>3</issue>
            <fpage>707</fpage>
            <page-range>707-18</page-range>
            <pub-id pub-id-type="pmid">870942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hejlesen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Underbjerg</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gj&#x000f8;rup</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sikjaer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rejnmark</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Haubek</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Dental anomalies and orthodontic characteristics in patients with pseudohypoparathyroidism.</article-title>
            <source>BMC Oral Health</source>
            <year>2019</year>
            <month>Dec</month>
            <day>31</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <pub-id pub-id-type="pmid">31892351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pereda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garin</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Garcia-Barcina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gener</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Beristain</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Iba&#x000f1;ez</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Perez de Nanclares</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Brachydactyly E: isolated or as a feature of a syndrome.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2013</year>
            <month>Sep</month>
            <day>12</day>
            <volume>8</volume>
            <fpage>141</fpage>
            <pub-id pub-id-type="pmid">24028571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elli</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>de Sanctis</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Madeo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Maffini</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Bordogna</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pirelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arosio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mantovani</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>2q37 Deletions in Patients With an Albright Hereditary Osteodystrophy Phenotype and PTH Resistance.</article-title>
            <source>Front Endocrinol (Lausanne)</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>604</fpage>
            <pub-id pub-id-type="pmid">31555217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elli</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Bordogna</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>de Sanctis</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Giachero</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Verrua</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Segni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mazzanti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Boldrin</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Toromanovic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spada</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mantovani</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Screening of PRKAR1A and PDE4D in a Large Italian Series of Patients Clinically Diagnosed With Albright Hereditary Osteodystrophy and/or Pseudohypoparathyroidism.</article-title>
            <source>J Bone Miner Res</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>1215</fpage>
            <page-range>1215-24</page-range>
            <pub-id pub-id-type="pmid">26763073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hasani-Ranjbar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jouyandeh</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Amoli</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Soltani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arzaghi</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>A patient with features of albright hereditory osteodystrophy and unusual neuropsychiatric findings without coding Gsalpha mutations.</article-title>
            <source>J Diabetes Metab Disord</source>
            <year>2014</year>
            <volume>13</volume>
            <fpage>56</fpage>
            <pub-id pub-id-type="pmid">24959527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Song</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>ZX</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YM</given-names>
              </name>
            </person-group>
            <article-title>Pseudohypoparathyroidism with basal ganglia calcification: A case report of rare cause of reversible parkinsonism.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>96</volume>
            <issue>11</issue>
            <fpage>e6312</fpage>
            <pub-id pub-id-type="pmid">28296742</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joseph</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Shoemaker</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Germain-Lee</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Increased prevalence of carpal tunnel syndrome in albright hereditary osteodystrophy.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>96</volume>
            <issue>7</issue>
            <fpage>2065</fpage>
            <page-range>2065-73</page-range>
            <pub-id pub-id-type="pmid">21525160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Landreth</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Malow</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Shoemaker</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Increased Prevalence of Sleep Apnea in Children with Pseudohypoparathyroidism Type 1a.</article-title>
            <source>Horm Res Paediatr</source>
            <year>2015</year>
            <volume>84</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-5</page-range>
            <pub-id pub-id-type="pmid">25925491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muniyappa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Aney</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Courville</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Brychta</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Germain-Lee</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Weinstein</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Skarulis</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Reduced insulin sensitivity in adults with pseudohypoparathyroidism type 1a.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>98</volume>
            <issue>11</issue>
            <fpage>E1796</fpage>
            <page-range>E1796-801</page-range>
            <pub-id pub-id-type="pmid">24030943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Lindert</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Bartels</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Noordam</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Spinal stenosis with paraparesis in albright hereditary osteodystrophy. Case report and review of the literature.</article-title>
            <source>Pediatr Neurosurg</source>
            <year>2008</year>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>337</fpage>
            <page-range>337-40</page-range>
            <pub-id pub-id-type="pmid">18552518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17327.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarathi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wade</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bandgar</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Intraarticular heterotopic ossification as the initial manifestation in a child with pseudohypoparathyroidism 1a.</article-title>
            <source>Indian J Pediatr</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>78</volume>
            <issue>6</issue>
            <fpage>745</fpage>
            <page-range>745-8</page-range>
            <pub-id pub-id-type="pmid">21229336</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
